Bausch Health Companies | VRX - Operating Profit

Stock Price
8.37
Daily Change
0.09 1.09%
Monthly
5.15%
Yearly
-24.32%
Q1 Forecast
8.16

Bausch Health Companies reported $719M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Amgen USD 3.96B 464M Dec/2025
ANI Pharmaceuticals USD 22.83M 7.66M Sep/2025
Aurora Cannabis CAD -55.67M 35.45M Sep/2025
Bausch Health Companies USD 719M 2M Dec/2025
Biogen USD 659.6M 192.2M Sep/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Canopy Growth CAD -14.3M 3.18M Sep/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Drreddys Laboratories INR 14.33B 2.51B Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Nektar Therapeutics USD -34.34M 15.43M Sep/2024
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Phibro Animal Health USD 25.53M 7.83M Dec/2024
Prestige Brands USD 82.49M 2.82M Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025
Zoetis USD 835M 101M Dec/2025